An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk

Abstract excerpt

One major drawback of preclinical models to test drug-induced liver injury (DILI) is their inability to predict the interindividual difference of DILI effect in a population. Consequently, a high number of molecules that passed preclinical phases, fail clinical trials, and many FDA-approved drugs were removed from the market due to idiosyncratic DILI. We use a proprietary-depleted human serum-based cell educating...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Induced Hepatotoxicity and Protection
• Share to Liver physiology and pathology
• Share to Pharmacogenetics and Drug Metabolism